Published in J Clin Invest on May 01, 1978
Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest (1984) 1.88
Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci U S A (1985) 1.86
Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 metabolism in calcium-deficient rats. Biochem J (1988) 0.80
Metabolic consequences of oral administration of 24,25-dihydroxycholecalciferol to uremic dogs. J Clin Invest (1980) 0.79
Suppressive effects of 24,25-dihydroxycholecalciferol on bone resorption induced by acute bilateral nephrectomy in rats. J Clin Invest (1981) 0.78
Take another CYP: confirming a novel mechanism for "idiopathic" hypercalcemia. J Clin Endocrinol Metab (2012) 0.77
Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes. Clin Cases Miner Bone Metab (2010) 0.77
Effects of High-Dose Vitamin D2 Versus D3 on Total and Free 25-Hydroxyvitamin D and Markers of Calcium Balance. J Clin Endocrinol Metab (2016) 0.76
Effect of low dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure. Arch Dis Child (1983) 0.75
Extraction of vitamin D metabolites by bones of normal adult dogs. J Clin Invest (1982) 0.75
Light- and electron-microscopic evaluation of the effects of 1,25-dihydroxyvitamin D3 on bone of thyroparathyroidectomized rats. Am J Pathol (1979) 0.75
Reversal of secondary hyperparathyroidism by cimetidine in chronically uremic dogs. J Clin Invest (1981) 0.75
Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature (1970) 5.66
Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab (1971) 4.81
Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest (1971) 3.67
"Activation" of vitamin D by the liver. J Clin Invest (1969) 2.42
Vitamin D-dependent calcium-binding protein. Purification and some properties. J Biol Chem (1968) 2.41
Parathyroid hormone: secretion and metabolism in vivo. Proc Natl Acad Sci U S A (1971) 2.04
Regulation of 25-hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone. Nat New Biol (1973) 2.00
Vitamin D and citrate metabolism; effect of vitamin D in rats fed diets adequate in both calcium and phosphorus. Am J Physiol (1958) 1.94
Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest (1972) 1.93
Vitamin D metabolism: the role of kidney tissue. Science (1971) 1.91
Multiple immunoreactive molecular forms of parathyroid hormone in human serum. 1. Proc Soc Exp Biol Med (1972) 1.86
Heterogeneity of parathyroid hormone. Clinical and physiologic implications. J Clin Invest (1973) 1.77
Vitamin D-dependent calcium-binding protein. Response to some physiological and nutritional variables. J Biol Chem (1968) 1.69
On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest (1971) 1.66
Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments. J Clin Invest (1973) 1.47
Experience with a radioimmunoassay of parathyroid hormone in human sera. Trans Assoc Am Physicians (1968) 1.44
Radioreceptor assay for 1 alpha,25-dihydroxyvitamin D3. Science (1974) 1.41
Stimulation of 24,25-dihydroxyvitamin D3 production by 1,25-dihydroxyvitamin D3. Science (1974) 1.33
Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol. J Clin Invest (1975) 1.33
Further studies on the interrelationship between parathyroid hormone and vitamin D. J Clin Invest (1966) 1.30
Metabolism of bovine parathyroid hormone. Immunological and biological characteristics of fragments generated by liver perfusion. J Clin Invest (1975) 1.30
Perfusion of the isolated parathyroid gland of the goat and sheep. Nature (1966) 1.29
The response of the small intestine to vitamin D. Isolation and properties of chick intestinal polyribosomes. Biochem J (1974) 1.19
Cytoplasmic and nuclear binding components for 1alpha25-dihydroxyvitamin D3 in chick parathyroid glands. Proc Natl Acad Sci U S A (1975) 1.16
Studies on the mechanism of action of calciferol VII. Localization of 1,25-dihydroxy-vitamin D3 in chick parathyroid glands. Biochem Biophys Res Commun (1975) 1.14
Studies on calciferol metabolism. I. Production of vitamin D metabolite 4B from 25-OH-cholecalciferol by kidney homogenates. Biochem Biophys Res Commun (1971) 1.13
Studies on the mode of action of calciferol. VI. Effect of 1,25-dihydroxy-vitamin D3 on RNA synthesis in the intestinal mucosa. Biochem Biophys Res Commun (1973) 0.98
Competitive binding assay for vitamin D and 25-OH vitamin D. J Clin Endocrinol Metab (1971) 0.95
Competitive protein binding assay for 24,25-dihydroxycholecalciferol. Biochem Biophys Res Commun (1976) 0.95
Isolation and properties of a calcium-binding protein from porcine parathyroid glands. Biochemistry (1974) 0.90
Acute actions of 1,25-dihydroxy-vitamin D3 in normal man: effect on calcium and parathyroid status. J Clin Endocrinol Metab (1977) 0.88
Competition by 24,25-dihydroxycholecalciferol in the competitive protein binding radioassay of 25-hydroxycalciferol. J Clin Endocrinol Metab (1976) 0.87
The effects of vitamin D metabolites and their analogues on the secretion of parathyroid hormone. Calcif Tissue Res (1976) 0.86
The hormone-like action of 1,25-(OH)2-cholecalciferol (a metabolite of the fat-soluble vitamin D) in the intestine. Vitam Horm (1974) 0.85
Studies on the metabolism of calciferol XII. Production in vitro of 1,24,25-(OH)3-vitamin D3 and a search for its occurrence in vivo. Arch Biochem Biophys (1975) 0.83
Cholecalciferol metabolites binding in porcine parathyroid glands. Steroids (1976) 0.79
On the Interpretation of Multi-Hit Survival Curves. Proc Natl Acad Sci U S A (1949) 5.96
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol (1997) 5.89
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol (2002) 3.98
Chemistry of tissues: 2. Polysaccharides showing blood group A-specificity and the nature of the constituent units of the stable carbohydrate residue of the A substance from pepsin. Biochem J (1946) 3.56
Effect of reactive pharmacy intervention on quality of hospital prescribing. BMJ (1990) 3.25
Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol (2003) 3.10
Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans serotype A. Mol Immunol (1980) 2.98
Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J Clin Microbiol (1995) 2.75
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer. Ann Oncol (1997) 2.71
Rapid identification of Candida species with species-specific DNA probes. J Clin Microbiol (1998) 2.65
Genetic differences between type I and type II Candida stellatoidea. Infect Immun (1989) 2.38
Antibody responses in bursa-deficient chickens. J Immunol (1966) 2.37
Bile acid transformations by microbial strains belonging to genera found in intestinal contents. Acta Pathol Microbiol Scand (1967) 2.33
Nucleotide sequence analysis of the 5.8S rDNA and adjacent ITS2 region of Candida albicans and related species. Yeast (1993) 2.26
Current trends in immunodiagnosis of candidiasis and aspergillosis. Rev Infect Dis (1984) 2.22
Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect Immun (1988) 2.11
Cell-wall glucans of Cryptococcus neoformans Cap 67. Carbohydr Res (1990) 2.08
Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer. J Clin Oncol (1995) 2.08
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol (1994) 2.02
Galactomannan antigenemia in invasive aspergillosis. Infect Immun (1979) 1.94
A radioimmunoassay for parathyroid hormone in man. Proc Soc Exp Biol Med (1968) 1.91
Ataxia-telangiectasia: an interdisciplinary approach to pathogenesis. Medicine (Baltimore) (1991) 1.89
Multiple immunoreactive molecular forms of parathyroid hormone in human serum. 1. Proc Soc Exp Biol Med (1972) 1.86
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer (1999) 1.80
Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr Res (1984) 1.79
Detection of antibodies and antigenemia in leukemic patients with candidiasis by enzyme-linked immunosorbent assay. J Infect Dis (1981) 1.77
Serological and cellular immune activity of peptidoglucomannan fractions of Candida albicans cell walls. Infect Immun (1974) 1.76
Proliferation of human lymphocytes in culture. Nature (1966) 1.76
A comparison of treatment planning techniques used in two randomised UK external beam radiotherapy trials for localised prostate cancer. Clin Oncol (R Coll Radiol) (2007) 1.75
Physiologic hyperparathyroidism in pregnancy. J Clin Endocrinol Metab (1972) 1.70
FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study. Br J Cancer (2000) 1.68
A test for the practical evaluation of male fertility by acridine orange (AO) fluorescence. Fertil Steril (1984) 1.68
Caclium, phosphorus, and bone in renal disease and transplantation. Arch Intern Med (1969) 1.66
Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol (1998) 1.66
On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest (1971) 1.66
Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide. Infect Immun (1980) 1.65
Sequence analysis of the internal transcribed spacer 2 (ITS2) from yeast species within the genus Candida. Curr Microbiol (1998) 1.64
A genetic register for von Hippel-Lindau disease. J Med Genet (1996) 1.61
Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol (1999) 1.59
Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans. Diagn Immunol (1984) 1.57
Rapid destructive osteoarthritis: clinical, radiographic, and pathologic features. Radiology (1992) 1.56
Comparative serological and cutaneous reactivity of candidal cytoplasmic proteins and mannan separated by affinity for concanavalin A. J Clin Microbiol (1977) 1.56
Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies. Infect Immun (1989) 1.55
The mutational spectrum in Waardenburg syndrome. Hum Mol Genet (1995) 1.55
Dissociation of mannan--serum complexes and detection of Candida albicans mannan by enzyme immunoassay variations. Clin Chem (1982) 1.54
Antibody-producing cells in division. Science (1967) 1.53
The role of phosphate in the secretion of parathyroid hormone in man. J Clin Invest (1970) 1.50
Parameters in 7-alpha-dehydroxylation of bile acids by anaerobic lactobacilli. Acta Pathol Microbiol Scand (1968) 1.50
Ethics. Human health research ethics. Science (2004) 1.49
A randomized study of the use of a customized immobilization system in the treatment of prostate cancer with conformal radiotherapy. Radiother Oncol (2000) 1.49
Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments. J Clin Invest (1973) 1.47
Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein. Br J Clin Pharmacol (2006) 1.46
Baseline quality of life predicts survival in patients with advanced colorectal cancer. Eur J Cancer (2002) 1.45
Illness and excretion of organophosphate metabolites four months after household pest extermination. Arch Environ Health (1992) 1.45
Application of radioimmunoassay to differentiation of adenoma and hyperplasia and to preoperative localization of hyperfunctioning parathyroid glands. N Engl J Med (1969) 1.44
Experience with a radioimmunoassay of parathyroid hormone in human sera. Trans Assoc Am Physicians (1968) 1.44
Endoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac-K liquid capsules. Aliment Pharmacol Ther (2012) 1.43
Predicting normal tissue injury in radiation therapy. Int J Radiat Oncol Biol Phys (1991) 1.43
Using intact nerve to bridge peripheral nerve defects: an alternative to the use of nerve grafts. J Hand Surg Am (2001) 1.42
Comparison of serum mannan, arabinitol, and mannose in experimental disseminated candidiasis. J Clin Microbiol (1984) 1.41
Comparison of enzyme immunoassay and gas-liquid chromatography for the rapid diagnosis of invasive candidiasis in cancer patients. J Clin Microbiol (1985) 1.41
Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy. Carbohydr Res (1988) 1.41
Monoclonal antibodies against Candida tropicalis mannan: antigen detection by enzyme immunoassay and immunofluorescence. J Clin Microbiol (1986) 1.40
Is supplementation with elemental diet feasible in patients undergoing pelvic radiotherapy? Clin Nutr (2005) 1.39
Influences of eating patterns on change to a low-fat diet. J Am Diet Assoc (1993) 1.39
Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest (1973) 1.39
Exonic STK11 deletions are not a rare cause of Peutz-Jeghers syndrome. J Med Genet (2006) 1.39
Circulating parathyroid hormone concentration in chronic renal insufficiency. Arch Intern Med (1969) 1.39
Microwave life-detection systems for searching human subjects under earthquake rubble or behind barrier. IEEE Trans Biomed Eng (2000) 1.39
Inhibition of norfloxacin absorption by antacids. Antimicrob Agents Chemother (1990) 1.38
"TRAUMATIC GASTRIC ULCERS.". Br Med J (1916) 1.38
Diseases associated with calcium pyrophosphate dihydrate crystal deposition. Am J Med (1974) 1.37
Isolated fecal microorganisms capable of 7-alpha-dehydroxylating bile acids. J Exp Med (1966) 1.36
Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol (1982) 1.36
Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy. Carbohydr Res (1992) 1.34
On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake. Kidney Int (1972) 1.34
Amyloid and non-amyloid forms of 5q31-linked corneal dystrophy resulting from kerato-epithelin mutations at Arg-124 are associated with abnormal turnover of the protein. J Biol Chem (2000) 1.34
Myositis ossificans with atypical clinical, radiographic, or pathologic findings: a review of 23 cases. Skeletal Radiol (1992) 1.34
Determination of bile acid conversion potencies of intestinal bacteria by screening in vitro and subsequent establishment in germfree rats. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 1.32
Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours. Eur J Cancer (1995) 1.31
Oral hydralazine therapy for chronic refractory heart failure. Circulation (1976) 1.30
Metabolism of bovine parathyroid hormone. Immunological and biological characteristics of fragments generated by liver perfusion. J Clin Invest (1975) 1.30
Characterization of protein and mannan polysaccharide antigens of yeasts, moulds, and actinomycetes. Curr Top Med Mycol (1985) 1.30
Comparison by ELISA of serum anti-Candida albicans mannan IgG levels of a normal population and in diseased patients. Mycopathologia (1980) 1.30
Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest (1986) 1.29
Distended left renal vein: CT/sonographic normal variant. AJR Am J Roentgenol (1980) 1.28
Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma. Br J Cancer (1999) 1.27
An electrophoretic karyotype for Candida albicans reveals large chromosomes in multiples. Mol Gen Genet (1987) 1.26
1,25-Dihydroxycholecalciferol--a hormonally active form of vitamin D. Recent Prog Horm Res (1974) 1.26
Excretion of 3beta-hydroxy-5-cholenoic and 3a-hydroxy-5a-cholanoic acids in urine of infants with biliary atresia. FEBS Lett (1971) 1.26